Qsemble Capital Management LP Purchases Shares of 21,161 Unum Group (NYSE:UNM)

Qsemble Capital Management LP acquired a new position in Unum Group (NYSE:UNM) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 21,161 shares of the financial services provider’s stock, valued at approximately $1,258,000.

Several other institutional investors have also modified their holdings of UNM. Versant Capital Management Inc grew its holdings in shares of Unum Group by 361.5% in the 2nd quarter. Versant Capital Management Inc now owns 503 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 394 shares during the last quarter. V Square Quantitative Management LLC acquired a new stake in Unum Group during the 2nd quarter worth about $26,000. Capital Performance Advisors LLP acquired a new stake in Unum Group during the 3rd quarter worth about $31,000. 1620 Investment Advisors Inc. purchased a new stake in Unum Group during the second quarter valued at about $29,000. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Unum Group in the third quarter worth about $37,000. Institutional investors and hedge funds own 86.57% of the company’s stock.

Insider Activity

In other news, CAO Walter Lynn Rice, Jr. sold 1,500 shares of the firm’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $69.56, for a total transaction of $104,340.00. Following the completion of the transaction, the chief accounting officer now directly owns 8,361 shares of the company’s stock, valued at approximately $581,591.16. This trade represents a 15.21 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Richard P. Mckenney sold 67,795 shares of the stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $54.98, for a total transaction of $3,727,369.10. Following the completion of the transaction, the chief executive officer now directly owns 1,065,868 shares of the company’s stock, valued at $58,601,422.64. This trade represents a 5.98 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 165,709 shares of company stock valued at $10,956,914. 0.93% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Morgan Stanley boosted their target price on shares of Unum Group from $62.00 to $64.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 30th. Wells Fargo & Company increased their price objective on Unum Group from $69.00 to $71.00 and gave the stock an “overweight” rating in a research note on Thursday, October 10th. Truist Financial lifted their target price on Unum Group from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, November 1st. JPMorgan Chase & Co. dropped their target price on Unum Group from $65.00 to $63.00 and set an “overweight” rating on the stock in a report on Thursday, October 3rd. Finally, Bank of America boosted their price objective on shares of Unum Group from $54.00 to $63.00 and gave the company a “neutral” rating in a research report on Thursday, October 10th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, Unum Group presently has a consensus rating of “Moderate Buy” and an average target price of $67.73.

Unum Group Stock Down 0.0 %

Shares of Unum Group stock opened at $76.20 on Wednesday. Unum Group has a 12-month low of $41.97 and a 12-month high of $76.72. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.32. The stock has a 50 day moving average price of $64.26 and a two-hundred day moving average price of $56.88. The stock has a market capitalization of $13.91 billion, a P/E ratio of 8.25, a PEG ratio of 1.12 and a beta of 0.76.

Unum Group (NYSE:UNM) last released its quarterly earnings results on Tuesday, October 29th. The financial services provider reported $2.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.10 by $0.03. Unum Group had a net margin of 13.76% and a return on equity of 15.21%. The company had revenue of $3.22 billion during the quarter, compared to analysts’ expectations of $3.26 billion. During the same period in the prior year, the company earned $1.94 earnings per share. The business’s quarterly revenue was up 4.0% compared to the same quarter last year. Equities analysts expect that Unum Group will post 8.53 earnings per share for the current year.

Unum Group announced that its Board of Directors has approved a stock buyback plan on Tuesday, July 30th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to reacquire up to 10% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.

Unum Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 25th were issued a dividend of $0.42 per share. The ex-dividend date of this dividend was Friday, October 25th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.20%. Unum Group’s dividend payout ratio (DPR) is presently 18.18%.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.